Drug Shortage Report for M-PREGABALIN
| Report ID | 141764 |
| Drug Identification Number | 02467291 |
| Brand name | M-PREGABALIN |
| Common or Proper name | Pregabalin |
| Company Name | MANTRA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2021-06-28 |
| Estimated end date | 2021-07-30 |
| Actual end date | 2021-07-20 |
| Shortage status | Resolved |
| Updated date | 2021-07-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2021-07-23 | French | Compare |
| v7 | 2021-07-23 | English | Compare |
| v6 | 2021-07-16 | French | Compare |
| v5 | 2021-07-16 | English | Compare |
| v4 | 2021-07-09 | French | Compare |
| v3 | 2021-07-09 | English | Compare |
| v2 | 2021-07-02 | French | Compare |
| v1 | 2021-07-02 | English | Compare |
Showing 1 to 8 of 8